Russian drug law hinders clinical trials

NatureRussiaTrialsA law aimed at improving Russians’ access to innovative medicines has backfired badly.

‘On the circulation of medicines’, a law that came into effect in September 2010, was intended to streamline the bureaucratic system for testing and registering new drugs in Russia. There were high hopes that it would also boost the nascent domestic pharmaceutical industry and attract foreign companies to run trials there. The law set a maximum cost and time limit for drug registrations, for example; mandated compensation for those injured during trials; and declared that drugs manufactured in Russia solely for export did not need to undergo registration.

[Read more at Nature or download PDF // January 18, 2012]


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s